GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Common Stock

Immunovia AB (OSTO:IMMNOV) Common Stock : kr2.26 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Common Stock?

Immunovia AB's quarterly common stock stayed the same from Sep. 2023 (kr2.26 Mil) to Dec. 2023 (kr2.26 Mil) and stayed the same from Dec. 2023 (kr2.26 Mil) to Mar. 2024 (kr2.26 Mil).

Immunovia AB's annual common stock stayed the same from Dec. 2021 (kr1.13 Mil) to Dec. 2022 (kr1.13 Mil) but then increased from Dec. 2022 (kr1.13 Mil) to Dec. 2023 (kr2.26 Mil).


Immunovia AB Common Stock Historical Data

The historical data trend for Immunovia AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Common Stock Chart

Immunovia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 1.13 1.13 1.13 2.26

Immunovia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 2.26 2.26 2.26 2.26

Immunovia AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Immunovia AB (OSTO:IMMNOV) Business Description

Traded in Other Exchanges
Address
Medicon Village, Scheelevagen 8, Lund, SWE, 223 63
Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The group's intangible and tangible assets are in Sweden, in the United States and in Germany.

Immunovia AB (OSTO:IMMNOV) Headlines

No Headlines